Chhaya Shah
Corporate Officer/Principal presso RADIUS HEALTH, INC.
Provenienza dei contatti di primo grado di Chhaya Shah
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Holding Company | Biotechnology | 46 | |
| Subsidiary | Pharmaceuticals: Major | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Chhaya Shah tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| NVN LIQUIDATION, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Investor Relations Contact | |
| ACTAVIA LIFE SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| TRISALUS LIFE SCIENCES, INC. | Medical Specialties | Director/Board Member Director of Finance/CFO Director/Board Member | |
| MALIN CORPORATION PLC | Biotechnology | Chief Executive Officer Founder Director/Board Member | |
| OKYO PHARMA LIMITED | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Brandon Point Industries Ltd.
 Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland. | Medical/Nursing Services | Founder Director/Board Member | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree Graduate Degree | |
| HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
| TIZIANA LIFE SCIENCES LTD | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| University of Baroda | College/University | Doctorate Degree Doctorate Degree | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Private Equity Investor | |
| CELYAD ONCOLOGY SA | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Graduate Degree | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | President Corporate Officer/Principal | |
| The University of Chicago | College/University | Doctorate Degree Undergraduate Degree | |
| NUVATION BIO INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Corporate Officer/Principal Director of Finance/CFO | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Human Resources Officer | |
| SERES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
Malin Life Sciences Holdings Ltd.
 Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
Patient Square Capital
 Patient Square Capital Investment ManagersFinance Patient Square Capital is an Independent Private Equity/Venture Capital firm founded by Jim Momtazee and Maria Walker. Patient Square Capital is headquartered in Menlo Park. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Founder | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Partner Therapeutics, Inc.
 Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Biotechnology | Founder | |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Chairman | |
| Nirvan Consultants LLC | President | ||
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 37 |
| Irlanda | 6 |
| Regno Unito | 4 |
| Bermuda | 3 |
| India | 2 |
Settori
| Health Technology | 33 |
| Consumer Services | 12 |
| Finance | 4 |
| Retail Trade | 2 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 220 |
| Corporate Officer/Principal | 112 |
| Independent Dir/Board Member | 81 |
| Undergraduate Degree | 39 |
| Director of Finance/CFO | 38 |
Contatti più connessi
| Insiders | |
|---|---|
| Andrew von Eschenbach | 32 |
| Jean-Pierre Garnier | 28 |
| Anthony Adam Rosenberg | 23 |
| Owen Hughes | 23 |
| Sean Murphy | 22 |
| Catherine Friedman | 20 |
| George Martin | 20 |
| Debasish Francois Roychowdhury | 18 |
| Jennifer Jarrett | 18 |
| Willard Dere | 16 |
| Gary Jacob | 16 |
| Kurt Graves | 15 |
| Richard Daly | 15 |
| Gary Sender | 14 |
| Jessica Hopfield | 14 |
- Borsa valori
- Insiders
- Chhaya Shah
- Connessioni Società
